Cary Street Partners Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	-$2.19K	–	348
2023 Q1	$2.19K	Hold	3	–	–	﹤0.01%	377
2022 Q4	$1.93K	Sell	3 -16	-84%	-$10.3K	﹤0.01%	420
2022 Q3	$13K	Buy	+19	New	+$13K	﹤0.01%	316